Live Analyst Rating Changes 46589 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Young Li
JEF

Young Li

Jefferies
Wall Street Analyst
★★★★★
#308
on 13Foresight · ranked by our own returns
33%
Success Rate
-16.1%
Average Return
6 of 18 calls profitable · -39.8% vs benchmark
S&P 500 (SPY)
📈 Across the calls we could measure, roughly 33% of Young Li's ratings turned a profit when each position was held for 2 year — averaging -16.1% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

3 Buy 4 Hold 0 Sell
Young's Stock Coverage 14 ratings · 2026-10-25
Company Date Position Consensus ⓘ Price Target ⓘ 2-Yr Return vs S&P 500 ⓘ
RXST
RxSight
 Sep 22, 2026 HOLD Sell
+80.4% avg upside
13 analysts
$5.75
14.46% Upside
 +1.8% ·
CH:ALC
Alcon
 Sep 22, 2026 BUY Strong Buy
+22.1% avg upside
36 analysts
$70.13
21.10% Upside
 +7.3% ·
STAA
Staar Surgical
 Sep 22, 2026 HOLD Hold
+52.0% avg upside
16 analysts
$23.00
1.68% Upside
 +8.1% ·
COO
Cooper Co
 Sep 10, 2026 BUY Strong Buy
+102.2% avg upside
21 analysts
$70.00
14.40% Upside
 +13.0% ·
ARAY
Accuray
 May 12, 2026 HOLD Strong Buy
+4613.1% avg upside
9 analysts
$0.35
168.98% Upside
 -58.1% ·
TMDX
TransMedics Group
 Oct 28, 2025 BUY Strong Buy
+35.2% avg upside
15 analysts
$145.00
104.95% Upside
 -44.5% ·
ENOV
Enovis
 May 30, 2025 BUY Strong Buy
+208.5% avg upside
39 analysts
$60.00
184.55% Upside
 -33.5% ·
HYPR
Hyperfine
 Mar 18, 2025 HOLD Buy
+172.1% avg upside
7 analysts
$1.20
65.61% Upside
 -20.4% ·
ATEC
Alphatec Holdings
 Jan 14, 2025 BUY Strong Buy
+49.2% avg upside
23 analysts
$19.00
70.99% Upside
 -0.1% ·
BLCO
Bausch + Lomb Corporation
 May 06, 2024 BUY Buy
+15.5% avg upside
20 analysts
$25.00
43.05% Upside
 +10.8% ·
SIBN
SI-Bone
 Mar 11, 2024 BUY Strong Buy
+21.3% avg upside
18 analysts
$30.00
39.69% Upside
 -20.3% ·
VREX
Varex Imaging
 May 23, 2023 HOLD Hold
+8.5% avg upside
10 analysts
$24.00
30.36% Upside
 -65.3% ·
VRAYQ
Viewray
 Apr 16, 2023 HOLD Strong Buy
+558333233.3% avg upside
12 analysts
$1.25
124999899.96% Upside
 · ·
CNMD
Conmed
 Oct 11, 2022 HOLD Hold
+32.3% avg upside
12 analysts
$85.00
72.60% Upside
 -15.8% ·
🔒 9 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Young Li — Frequently Asked Questions
How accurate are Young Li's stock ratings?
Based on the calls 13Foresight could measure, about 44% of Young's ratings were profitable over a one-year hold, with an average return of -7.3% per rating, or +21.8% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.
How is Young ranked on 13Foresight?
Young Li is currently ranked #308 with a 5-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Young cover?
Young most recently has ratings on RXST, CH:ALC, STAA, COO, ARAY, TMDX, ENOV, HYPR, ATEC, BLCO, SIBN, VREX and 2 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.